Evidence map›Paper›PMID 29213743›Full record

ReviewDementia & neuropsychologia

Treatment of Alzheimer's disease in Brazil: II. Behavioral and psychological symptoms of dementia.

Francisco de Assis Carvalho do Vale, Ylmar Corrêa Neto, Paulo Henrique Ferreira Bertolucci, João Carlos Barbosa Machado, Delson José da Silva, Nasser Allam, Márcio Luiz Figueredo Balthazar, Group Recommendations in Alzheimer’s Disease and Vascular Dementia of the Brazilian Academy of Neurology

Abstract readReview
In one paragraph

Review in Dementia & neuropsychologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francisco de Assis Carvalho do ValeFederal University of São Carlos (UFSCar), Department of Medicine (DMed), São Carlos SP, Brazil.
Ylmar Corrêa NetoFederal University of Santa Catarina (UFSC), Department of Internal Medicine, Florianópolis SC, Brazil.
Paulo Henrique Ferreira BertolucciFederal University of São Paulo (UNIFESP), Sector of Behavioral Neurology - Escola Paulista de Medicina, São Paulo SP, Brazil.
João Carlos Barbosa MachadoAurus IEPE - Institute of Research and Education on Aging of Belo Horizonte; Faculty of Medical Sciences of Minas Gerais (FCMMG), Department of Geriatric Medicine of Hospital Mater Dei, Belo Horizonte MG, Brazil.
Delson José da SilvaNeurosciences Center of Hospital das Clinicas of the Federal University of Goiás (UFG). Integrated Institute of Neurosciences (IINEURO), Goiânia GO, Brazil.
Nasser AllamUniversity of Brasilia (UnB), Laboratory of Neurosciences and Behavior, Brasília DF, Brazil.
Márcio Luiz Figueredo BalthazarUniversity of Campinas (UNICAMP), Faculty of Medical Sciences (FCM), Department of Neurology, Campinas SP, Brazil.
Group Recommendations in Alzheimer’s Disease and Vascular Dementia of the Brazilian Academy of Neurology

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article reports the recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology for the treatment of Alzheimer's disease (AD) in Brazil, with special focus on behavioral and psychological symptoms of dementia (BPSD). It constitutes a revision and broadening of the 2005 guidelines based on a consensus involving researchers (physicians and non-physicians) in the field. The authors carried out a search of articles published since 2005 on the MEDLINE, LILACS and Cochrane Library databases. The search criteria were pharmacological and non-pharmacological treatment of the behavioral and psychological symptoms of AD. Studies retrieved were categorized into four classes, and evidence into four levels, based on the 2008 recommendations of the American Academy of Neurology. The recommendations on therapy are pertinent to the dementia phase of AD. Recommendations are proposed for the treatment of BPSD encompassing both pharmacological (including acetyl-cholinesterase inhibitors, memantine, neuroleptics, anti-depressives, benzodiazepines, anti-convulsants plus other drugs and substances) and non-pharmacological (including education-based interventions, physiotherapy, occupational therapy, music therapy, therapy using light, massage and art therapy) approaches. Recommendations for the treatment of cognitive disorders of AD symptoms are included in a separate article of this edition.

Indexed as

Alzheimer’s diseasebehavioral and psychological symptoms of dementiadementiatreatment

Identifiers

PMID29213743
PMCPMC5619478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.